Alder's Latham Talks Creativity, Antibodies, Funding a Start-up
By Jennifer Boggs
Monday, August 26, 2013
Even before he helped found antibody firm Alder Biopharmaceuticals Inc. in 2004, Chief Scientific Officer John Latham had a developed a taste for small firms and start-ups.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.